On October 15, 2020 TAE Life Sciences (TLS), a biologically-targeted radiation therapy company developing a breakthrough, accelerator-based boron neutron capture therapy (BNCT) system, reported that Bruce Bauer, Chief Executive Officer, will present at the 22nd Annual Southern California Biomedical Council (SoCalBio) Conference (Press release, TAE Life Sciences, OCT 15, 2020, View Source [SID1234568526]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Friday, October 23, 2020
Time: 11:15 – 11:27 AM PST

TLS’ presentation is part of the Nurturing Innovators track that showcases emerging biosciences companies. Mr. Bauer will provide an overview of the company and its recent business milestones.